Bumetanide Nasal Spray (Bumetanide) - What are the side effects of Enbumyst?

Bumetanide Nasal Spray (Bumetanide)-Enbumyst is a cyclic diuretic that is widely used to treat edema caused by congestive heart failure, liver and kidney diseases (including adult nephrotic syndrome). These medications improve a patient's quality of life by helping to relieve fluid retention caused by heart or kidney dysfunction by promoting the elimination of fluids from the body.

The use of Enbumyst has certain contraindications. For example, patients who have anuria, hepatic coma, or have been allergic to bumetanide should not use this drug. This is because in these cases, using Enbumyst may aggravate the condition, posing greater risks. In addition, Enbumyst, as a diuretic, may cause fluid, electrolyte, and metabolic abnormalities. These abnormalities manifest as excess fluid loss from the body, which may cause dehydration, reduced blood volume, and an increased risk of blood clots.

During the use of Enbumyst, patients may experience some adverse reactions. The most common ones include hypovolemia, headache, muscle cramps, dizziness, hypotension, nausea, etc. The incidence of encephalopathy is also higher in patients with pre-existing liver disease. The occurrence of these adverse reactions is closely related to factors such as the patient's overall health condition, medication dosage, and the presence of electrolyte deficiency. The risk of such adverse reactions is more significant especially for the elderly or patients using higher doses.

During treatment, if the patient develops symptoms such as azotemia and oliguria, especially in cases of severe progressive kidney disease, the use of Enbumyst should be stopped immediately to avoid possible serious consequences. At the same time, ototoxicity is another aspect that needs attention. Although the probability of occurrence is low at recommended doses, the risk of ototoxicity still needs to be taken seriously at high doses or when renal excretory function is impaired.

In addition,Enbumyst is not suitable for use in patients with significant nasal mucosal or structural abnormalities, such as acute rhinitis attacks or nasal congestion due to other causes. This is because in these cases, the absorption and efficacy of the drug may be affected, which may even lead to increased discomfort or side effects.

Reference materials:https://www.drugs.com/enbumyst.html